AI-driven small molecule discovery, which underlies most drugs on the market, is a challenge being tackled through science and technology ...
Anthropic also went a step further, saying it would develop drugs of its own. Head of life sciences Eric Kauderer-Abrams said ...
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
Xaira is an integrated biotechnology company built to deliver on the promise of AI to help transform the drug discovery and development process Dr. Ian McCaffery joins from AbbVie, where he served as ...
Tempus AI Inc. (NASDAQ:TEM) is one of the top 10 hidden AI stocks to buy. On May 31, Tempus AI launched the next generation ...
Design of targeted protein degraders is more than target degradation. Linker architecture, molecular flexibility, solubility, permeability, synthesis, purification, and formulation can all influence ...
Process analytical technology enables data-driven scale-up by embedding real-time analytics from development through ...
A new laser technique decodes molecular vibrations to predict whether a drug will be effective, potentially cutting years ...
Researchers at the Purdue Institute for Cancer Research (PICR) have developed a next-generation technology platform designed to accelerate one of the slowest and most challenging stages of cancer drug ...
Cholesterol-related heart disease remains the leading cause of death worldwide, and while doctors have more tools than ever ...
The drug discovery services market is projected to advance from US$ 21.5 billion in 2026 to US$ 67.3 billion by 2035, compounding at a CAGR of 13.5 per cent over the forecast period. The market had ...
Discover how automation, AI, and organoid technologies are improving drug discovery through scalable workflows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results